Relugolix, sold under the brand names Orgovyx and Relumina among others, is a gonadotropin-releasing hormone antagonist (GnRH receptor antagonist) medication...
23 KB (1,984 words) - 08:48, 26 April 2025
Relugolix/estradiol/norethisterone acetate, sold under the brand names Myfembree and Ryeqo, is a fixed-dose combination hormonal medication which is used...
13 KB (894 words) - 19:45, 17 December 2024
antagonistic effect, while other GnRH antagonists, such as elagolix and relugolix, are non-peptide and small-molecule compounds. GnRH antagonists compete...
19 KB (1,915 words) - 11:05, 8 February 2025
are structurally related to GnRH – or small-molecules like elagolix and relugolix, which are structurally distinct from and unrelated to GnRH analogues...
6 KB (514 words) - 19:52, 27 March 2024
introduction of elagolix in the United States and Canada was followed by that of relugolix (brand name Relumina), the next second-generation GnRH antagonist, in...
64 KB (6,216 words) - 15:58, 24 January 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
36 KB (3,608 words) - 15:42, 17 February 2025
symptoms of metastases. In these people, GnRH antagonists like degarelix or relugolix are given instead, and can also rapidly reduce testosterone levels. Reducing...
81 KB (9,190 words) - 07:55, 19 May 2025
Cetrorelix Degarelix Ganirelix Ozarelix Elagolix Linzagolix Opigolix Relugolix Sufugolix Current research is looking into pharmacoperones, or chemical...
10 KB (1,054 words) - 02:33, 1 August 2024
H01CC04 Linzagolix H01CC53 Elagolix, estradiol and norethisterone H01CC54 Relugolix, estradiol and norethisterone "ATC (Anatomical Therapeutic Chemical Classification...
2 KB (290 words) - 07:22, 31 December 2022
Exemestane L02BX01 Abarelix L02BX02 Degarelix L02BX03 Abiraterone L02BX04 Relugolix L02BX53 Abiraterone and corticosteroids "ATC (Anatomical Therapeutic Chemical...
2 KB (236 words) - 04:39, 23 December 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
9 KB (881 words) - 15:48, 11 February 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
22 KB (2,323 words) - 07:23, 17 May 2025
years. The National Institute of Health and Care Excellence approves relugolix, used to treat the symptoms of endometriosis, for use by the NHS in England...
182 KB (20,193 words) - 23:34, 19 May 2025
but was subsequently discontinued. It seems to have been supplanted by relugolix (TAK-385), which is also under development by Takeda for the treatment...
7 KB (562 words) - 19:09, 23 January 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
29 KB (3,499 words) - 17:12, 25 January 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
18 KB (1,655 words) - 13:19, 26 October 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
26 KB (2,697 words) - 01:40, 9 May 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
11 KB (1,114 words) - 23:42, 22 March 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
17 KB (1,376 words) - 03:15, 18 May 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
50 KB (5,442 words) - 02:02, 9 May 2025
orally active GnRH antagonist to be introduced for medical use 2019: Relugolix is the second orally active GnRH antagonist to be introduced for medical...
160 KB (15,253 words) - 07:29, 9 May 2025
non-peptide and orally active GnRH antagonists, elagolix (Orilissa) and relugolix (Relumina), were introduced for medical use in 2018 and 2019, respectively...
231 KB (25,325 words) - 14:52, 3 May 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
8 KB (794 words) - 07:50, 29 April 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
42 KB (3,463 words) - 19:26, 19 May 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
23 KB (2,721 words) - 07:00, 7 August 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
11 KB (820 words) - 13:21, 28 April 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
52 KB (4,092 words) - 06:27, 13 May 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
846 bytes (51 words) - 18:00, 24 September 2018
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
3 KB (280 words) - 10:25, 8 January 2025
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
10 KB (646 words) - 02:44, 7 March 2025